• search

Chancroid vaccine promising in pigs

Written by: Staff

NEW YORK, May 13 (Reuters) A vaccine against the bug that causes the sexually transmitted disease known as chancroid has shown promise in experiments conducted in pigs, scientists report. Not only would such a vaccine prevent or reduce the painful open sores of chancroid on the genitals, it could also reduce the transmission of HIV, senior researcher Dr Christopher Elkins told Reuters Health.

Chancroid, a highly contagious STD, is very common in Africa and becoming more common in the United States. Chancroid can be effectively treated with antibiotics. Left untreated, chancroid may facilitate the transmission of HIV, the virus that causes AIDS.

Elkins, at the University of North Carolina in Chapel Hill, and his associates purified a key part of Haemophilus ducreyi, the bug that causes chancroid, and used it to vaccinate pigs on days 1, 21, and 42. Three weeks later, they inoculated the animals' skin with Haemophilus ducreyi. They report their results in the journal Infection and Immunity.

Even though characteristic chancroid lesions developed on the vaccinated pigs, the lesions 7 days later were smaller and less inflamed compared with lesions in pigs that were vaccinated with a placebo.

At the same time, lesions of the vaccinated pigs were sterile, whereas all 17 biopsies from sham-vaccinated pigs yielded viable Haemophilus ducreyi. Moreover, the blood of vaccinated pigs had high levels of antibodies against the chancroid bug.

Prevention of chancroid lesions may reduce transmission of HIV, because ''high concentrations'' of HIV-susceptible cells are present in chancroid ulcers, Elkins explained.


For Daily Alerts

For Breaking News from Oneindia
Get instant news updates throughout the day.

Notification Settings X
Time Settings
Clear Notification X
Do you want to clear all the notifications from your inbox?
Settings X
We use cookies to ensure that we give you the best experience on our website. This includes cookies from third party social media websites and ad networks. Such third party cookies may track your use on Oneindia sites for better rendering. Our partners use cookies to ensure we show you advertising that is relevant to you. If you continue without changing your settings, we'll assume that you are happy to receive all cookies on Oneindia website. However, you can change your cookie settings at any time. Learn more